HCAT Insider Trading

Insider Ownership Percentage: 2.50%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $1,178,383.46

Health Catalyst Insider Trading History Chart

This chart shows the insider buying and selling history at Health Catalyst by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$22ksoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$1M$0$1MTotal Insider BuyingTotal Insider Selling

Health Catalyst Share Price & Price History

Current Price: $3.84
Price Change: Price Increase of +0.09 (2.40%)
As of 04/17/2025 05:00 PM ET

This chart shows the closing price history over time for HCAT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMarApr$3.84Closing price on 04/18/25:

SEC Filings (Institutional Ownership Changes) for Health Catalyst (NASDAQ:HCAT)

85.00% of Health Catalyst stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at HCAT by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$8.04Mbought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$20M-$10M$0$10M$20MTotal InflowsTotal Outflows
Health Catalyst logo
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.
Read More on Health Catalyst

Today's Range

Now: $3.84
Low: $3.61
High: $3.89

50 Day Range

MA: $4.46
Low: $3.70
High: $5.55

52 Week Range

Now: $3.84
Low: $3.56
High: $9.24

Volume

465,545 shs

Average Volume

613,824 shs

Market Capitalization

$269.61 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.43

Who are the company insiders with the largest holdings of Health Catalyst?

Health Catalyst's top insider shareholders include:
  1. Daniel D Burton (CEO)
  2. Kevin Lee Freeman (Insider)
  3. Bryan Truman Hunt (CFO)
  4. Daniel Lesueur (COO)
  5. Benjamin Landry (General Counsel)
  6. Linda Llewelyn (Insider)
  7. Jason Alger (CFO)
  8. Duncan Gallagher (Director)
  9. Jason Alger (CAO)
Learn More about top insider investors at Health Catalyst.

Who are the major institutional investors of Health Catalyst?

Health Catalyst's top institutional investors include:
  1. Nepsis Inc. — 2.98%
  2. SG Americas Securities LLC — 0.12%
  3. Dynamic Advisor Solutions LLC — 0.06%
  4. Summit Global Investments — 0.04%
Learn More about top institutional investors of Health Catalyst stock.

Which institutional investors are buying Health Catalyst stock?

In the last quarter, HCAT stock was bought by institutional investors including:
  1. Nepsis Inc.
  2. SG Americas Securities LLC
  3. Summit Global Investments
  4. Dynamic Advisor Solutions LLC